Reports link GLP-1 medications like Ozempic and Mounjaro to vision loss, prompting concerns over their safety.

Experts from five states have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind, ...

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...

Researchers looked at the nine people who had vision problems while using the drugs and is one of several that have ...

A small percentage have had vision problems, but a direct causal link with the drugs has not been established.

While reports of patients on semaglutide and tirzepatide with vision problems are still rare ... drugs in the first place because they have diabetes or obesity, as well as other cardiovascular ...

In the past 30 years, diabetes has been a growing problem for an alarming number of Americans — roughly doubling in the past 30 years. Type two diabetes is ...

Researchers from the University of Virginia Center for Diabetes Technology have found that continuous glucose monitor data can predict if someone is at risk of developing eye, kidney and nerve ...

Experts warn Ozempic and Mounjaro may cause sudden, irreversible blindness as patients report vision loss after taking the weight loss drugs.

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular ...

Glycaemic control in young people improved by automated insulin delivery systems Screening for eye disease can also detect liver damage Diabetes and obesity linked to greater risk of liver cancer ...